Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Aug 1;8(3):33.
doi: 10.3390/jfb8030033.

Immunological Responses to Total Hip Arthroplasty

Kenny Man  1 , Lin-Hua Jiang  2 , Richard Foster  3 , Xuebin B Yang  4   5
Affiliations
Review

Immunological Responses to Total Hip Arthroplasty

Kenny Man et al. J Funct Biomater. .

Abstract

The use of total hip arthroplasties (THA) has been continuously rising to meet the demands of the increasingly ageing population. To date, this procedure has been highly successful in relieving pain and restoring the functionality of patients' joints, and has significantly improved their quality of life. However, these implants are expected to eventually fail after 15-25 years in situ due to slow progressive inflammatory responses at the bone-implant interface. Such inflammatory responses are primarily mediated by immune cells such as macrophages, triggered by implant wear particles. As a result, aseptic loosening is the main cause for revision surgery over the mid and long-term and is responsible for more than 70% of hip revisions. In some patients with a metal-on-metal (MoM) implant, metallic implant wear particles can give rise to metal sensitivity. Therefore, engineering biomaterials, which are immunologically inert or support the healing process, require an in-depth understanding of the host inflammatory and wound-healing response to implanted materials. This review discusses the immunological response initiated by biomaterials extensively used in THA, ultra-high-molecular-weight polyethylene (UHMWPE), cobalt chromium (CoCr), and alumina ceramics. The biological responses of these biomaterials in bulk and particulate forms are also discussed. In conclusion, the immunological responses to bulk and particulate biomaterials vary greatly depending on the implant material types, the size of particulate and its volume, and where the response to bulk forms of differing biomaterials are relatively acute and similar, while wear particles can initiate a variety of responses such as osteolysis, metal sensitivity, and so on.

Keywords: immunological response; implant materials; total hip arthroplasty; wear particles.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Kavanagh B.F., Dewitz M.A., Ilstrup D.M., Stauffer R.N., Coventry M.B. Charnley total hip arthroplasty with cement. Fifteen-year results. J. Bone Jt. Surg. 1989;71:1496–1503. doi: 10.2106/00004623-198971100-00007. - DOI - PubMed
    1. Kandala N.B., Connock M., Pulikottil-Jacob R., Sutcliffe P., Crowther M.J., Grove A., Mistry H., Clarke A. Setting benchmark revision rates for total hip replacement: Analysis of registry evidence. BMJ. 2015;350:h756. doi: 10.1136/bmj.h756. - DOI - PubMed
    1. Kurtz S., Ong K., Lau E., Mowat F., Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J. Bone Jt. Surg. 2007;89:780–785. doi: 10.2106/00004623-200704000-00012. - DOI - PubMed
    1. Herberts P., Malchau H. Long-term registration has improved the quality of hip replacement—A review of the Swedish THR Register comparing 160,000 cases. Acta Orthop. Scand. 2000;71:111–121. doi: 10.1080/000164700317413067. - DOI - PubMed
    1. Ulrich S.D., Seyler T.M., Bennett D., Delanois R.E., Saleh K.J., Thongtrangan I., Kuskowski M., Cheng E.Y., Sharkey P.F., Parvizi J., et al. Total hip arthroplasties: What are the reasons for revision? Int. Orthop. 2008;32:597–604. doi: 10.1007/s00264-007-0364-3. - DOI - PMC - PubMed